MightyBeef
voted
Foreword:
Got any suggestion regarding our moomoo App? Want to share some brilliant ideas to make moomoo an even better platform? Join #Talk to PM, leave your ideas, and our Product Managers will be there for you!
Greetings, mooers!
Welcome back to "What's new in moomoo"!
This time we have brought you with the optimized layout of the "Me" page starting from iOS v12.14. Let's check out the new look!
Got any suggestion regarding our moomoo App? Want to share some brilliant ideas to make moomoo an even better platform? Join #Talk to PM, leave your ideas, and our Product Managers will be there for you!
Greetings, mooers!
Welcome back to "What's new in moomoo"!
This time we have brought you with the optimized layout of the "Me" page starting from iOS v12.14. Let's check out the new look!
8
2
MightyBeef
commented on
$Tesla (TSLA.US)$ put buy 1050, hoping it be filled. come back some moments later saw it at 1040$. darn. should have put buy at 1030 earlier.
3
I'm a beginner investor with a few positions in Tesla and Apple. I try to continuously improve my trading mindset by always learning and having an open mind to people around me - the power of YouTube, Google and the moomoo community.
With the recent volatility, I have to remain disciplined and control my emotions. I trust that those two companies that I believe in will do good bec...
With the recent volatility, I have to remain disciplined and control my emotions. I trust that those two companies that I believe in will do good bec...
1
MightyBeef
commented on
$Tesla (TSLA.US)$ is it too late to buy now
4
4
MightyBeef
liked
$Pfizer (PFE.US)$ Analyst Louise Chen said that on Pfizer's upcoming investor day, the company's new crown vaccine and new crown oral drug Paxlovid will be the focus of attention. If the company’s management can guarantee the durability of vaccine sales and the peak sales potential of oral drugs, this may be a positive catalyst.
According to analysts, her peak sales potential for these two businesses is estimated to be between US$50 billion and US$60 billion. She pointed out that the rising number of new crown infections and concerns about the Ome Keron variant, and the weakened effectiveness of the existing new crown vaccine against the Ome Keron variant, can support her view; although there are other pharmaceutical companies in the Research on next-generation antibodies, but it may not be available until later in 2022.
Article excerpted from the US Stock Research Agency
According to analysts, her peak sales potential for these two businesses is estimated to be between US$50 billion and US$60 billion. She pointed out that the rising number of new crown infections and concerns about the Ome Keron variant, and the weakened effectiveness of the existing new crown vaccine against the Ome Keron variant, can support her view; although there are other pharmaceutical companies in the Research on next-generation antibodies, but it may not be available until later in 2022.
Article excerpted from the US Stock Research Agency
16
MightyBeef
liked
$Salesforce (CRM.US)$ $Novavax (NVAX.US)$ US markets tumbled; Salesforce tumbled on guidance update; Novavax rose on Omicron variant vaccine update.
11